RNA Technologies Enabling Drug Discovery and Development
This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives:
• Industry Drivers and Challenges
• Technology Snapshot and Trends
• Clinical Pipeline Analysis
• Overview of the IP Landscape
• Innovator Profiles
• Future Roadmap
The RNA therapy platforms covered include:
• Splice-Switching Oligonucletides (SSO)
• Other Anti-Sense Oligonucleotide (ASO)
• Aptamers
• RNA-interference
• mRNA
• saRNA
An appendix is included, comprising lists of major industry influencers found in the study.
- Executive Summary
- Research Scope: RNA Therapies Redefining the Healthcare Landscape
- Analysis Framework: Frost & Sullivan's Core Value
- Research Methodology: Five Steps Towards Success
- Key Findings
- RNA Therapies: Industry Overview
- RNA is the Rising Star of Transformative Therapy Platforms
- Industry Accelerators and Challenges
- RNA Delivery: Technology Segmentation
- RNA Therapies: Technology Segmentation
- Molecular Insights Across RNA Therapy
- Technology Trends & Clinical Pipeline
- Alternative Splicing Induced by SSO Therapies
- Clinical Pipeline Analysis for SSO Therapies for SMA and DMD
- Post-transcriptional Modifications by ASO
- Clinical Pipeline Overview for ASO Therapies
- Emerging Clinical Pipeline for ASO Therapies
- Early Phase ASO Therapies
- Inhibition of Ligand Binding by Aptamer
- Clinical Pipeline Analysis for Aptamer Therapies
- Landmark Year for RNA Interference Therapy Platform
- Clinical Analysis of RNA Interference Therapeutics
- Overview of the Emerging Landscape for mRNA Therapies
- Clinical Pipeline Analysis of mRNA Therapies
- saRNA: The Rising Participant in RNA-based Therapies
- Overview of The Patent Landscape
- Patenting Trends for ASO Technologies
- Patenting Trends for RNAi Platforms
- Patenting Trends for mRNA Technologies
- Innovation Profiles
- Targeted RNAi Technology for Enhanced Disease Management
- Enabling Targeted Delivery of RNAi Therapeutics
- Developing Stable and Non-immunogenic mRNA Therapies
- Fueling Novel RNA Therapy and Delivery Platforms
- Enabling Potent Antisense Therapeutics
- Future Perspectives
- RNA Platforms likely to Transform the Future of Health & Wellness
- Navigating Through The Future Landscape for RNA Technologies
- Growth Opportunities and Companies to Action
- Growth Opportunity 1: ASO Therapies
- Growth Opportunity 2: RNAi Therapies
- Growth Opportunity 3: mRNA Therapies
- Strategic Imperatives for Success and Growth
- Key Industry Influencers
- Industry Interactions
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook